CohBar Advances First-in-Class Mitochondria Based Therapeutic to IND-Enabling Activities Sep 30, 2016
CohBar, Inc. Announces Preclinical Proof-of-principle Publication for SHLP Mitochondrial-derived Peptides and their Role in Metabolic Regulation and Cell Viability Apr 11, 2016
CohBar, Inc. to Announce 2015 Fourth Quarter Financial Results and Host Conference Call for Shareholders on March 9, 2016 Feb 24, 2016
